SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549

SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No....) .......................
(Name of Issuer)
Curon Medical Inc.
(Title of Class of Securities)
......Common
.....................................
(CUSIP Number)
....231292103
.........................................
(Date of Event Which Requires Filing of 
thisStatement)
January 3, 2006
Check the appropriate box to designate the

rule pursuant to which this Schedule is filed:
[ X] Rule 13d-1(b)

[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled
out for a reporting person's initial filing on 
this form with
respect to the subject class of securities,
and for any
subsequent amendment containing information which
would alter the disclosures provided in a prior
cover page.
The information required in the remainder of this 
cover page
 shall not be deemed to be
"filed" for the purpose of Section 18 of the Securities
 Exchange Act of 1934 ("Act") or
otherwise subject to the liabilities of that section
 of the Act but shall be subject to all
other provisions of the Act (however, see the Notes).
CUSIP No. G02995101
(1)Names of reporting persons. I.R.S. Identification 
Nos. of above persons (entities only)

Goldman Capital Management Inc.
13-3279572
(2) Check the appropriate box if a member of a
 group (see instructions)
(a)
(b)
(3) SEC use only
(4) Citizenship or place of organization
New York
Number of shares beneficially owned by each 
reporting person with:
(5)Sole voting power  2407670 
(6)Shared voting power 
(7)Sole dispositive power 
(8)Shared dispositive power
 
(9)Aggregate amount beneficially owned by each 
reporting person
2470670
(10)Check if the aggregate amount in Row (9) 
excludes certainshares (see instructions)
(11)Percent of class represented by amount in Row 9
5.6
(12)Type of reporting person (see instructions)
BD
Instructions for Cover Page
(1)Names and I.R.S. Identification Numbers of 
Reporting Persons---Furnish the full legal
name of each person for whom the report is 
filed---i.e., each person required to sign the
schedule itself---including each member of a 
group. Do not include the name of a person
required to be identified in the report but
 who is not a reporting person. Reporting
persons are also requested to furnish their
 I.R.S. identification numbers, although
disclosure of such numbers is voluntary, not
 mandatory (see "SPECIAL INSTRUCTIONS FOR
COMPLYING WITH SCHEDULE 13G", below).
(2)If any of the shares beneficially owned by
 a reporting person are held as a member of a
group and that membership is expressly affirmed,
 please check row 2(a). If the reporting
person disclaims membership in a group or 
describes a relationship with other person but
does not affirm the existence of a group, 
please check row 2(b) [unless it is a joint
filing pursuant to Rule 13d-1(k)(1) in which
 case it may not be necessary to check row
2(b)].
(3)The third row is for SEC internal use;
 please leave blank.
(4) Citizenship or Place of Organization---
Furnish citizenship if the named reporting
person is a natural person. Otherwise, furnish
 place of organization.
(5)-(9), (11)Aggregated Amount Beneficially Owned
 By Each Reporting Person, etc.---Rows (5)
through (9) inclusive, and (11) are to be completed
 in accordance with the provisions of
Item 4 of Schedule 13G. All percentages are to be
 rounded off to the nearest tenth (one

place after decimal point).
(10)Check if the aggregate amount reported as 
beneficially owned in row 9 does not include
shares as to which beneficial ownership is 
disclaimed pursuant to Rule 13d-4 under the

Securities Exchange Act of 1934.
(12)Type of Reporting Person---Please classify 
each "reporting person" according to the
following breakdown (see Item 3 of Schedule 13G)
 and place the appropriate symbol on the
form:
Category
Symbol
Broker Dealer
BD
Bank
BK
Insurance Company
IC
Investment Company
IV
Investment Adviser
IA
Employee Benefit Plan or Endowment Fund
EP
Parent Holding Company/Control Person
HC
Savings Association
SA
Church Plan
CP
Corporation
CO
Partnership
PN
Individual
IN
Other
OO
Notes:
Attach as many copies of the second part of the cover 
page as are needed, one reportingperson per page.
Filing persons may, in order to avoid unnecessary 
duplication, answer items on the
schedules (Schedule 13D, 13G, or 14D-1) by appropriate
 cross references to an item or items
on the cover page(s). This approach may only be used 
where the cover page item or items
provide all the disclosure required by the schedule 
item. Moreover, such a use of a cover
page item will result in the item becoming a part of
 the schedule and accordingly being
considered as "filed" for purposes of Section 18 of 
the Securities Exchange Act or
otherwise subject to the liabilities of that section
 of the Act.
Reporting persons may comply with their cover page 
filing requirements by filing either
completed copies of the blank forms available from
 the Commission, printed or typed
facsimiles, or computer printed facsimiles, provided 
the documents filed have identical

formats to the forms prescribed in the Commission's
 regulations and meet existing
Securities Exchange Act rules as to such matters as 
clarity and size (Securities Exchange
Act Rule 12b-12).
SPECIAL INSTRUCTIONS FOR COMPLYING WITH SCHEDULE 13G

Under Sections 13(d), 13(g), and 23 of the Securities
 Exchange Act of 1934 and the rules
and regulations thereunder, the Commission is 
authorized to solicit the information
required to be supplied by this schedule by certain
 security holders of certain issuers.
Disclosure of the information specified in this 
schedule is mandatory, except for I.R.S.
identification numbers disclosure of which is voluntary.
 The information will be used for
the primary purpose of determining and disclosing the 
holdings of certain beneficial owners
of certain equity securities. This statement will be 
made a matter of public record.
Therefore, any information given will be available for
 inspection by any member of the
public.
Because of the public nature of the information, the 
Commission can utilize it for a
variety of purposes, including referral to other 
governmental authorities or securities
self-regulatory organizations for investigatory 
purposes or in connection with litigation
involving the Federal securities laws or other civil,
 criminal or regulatory statues or
provisions. I.R.S. identification numbers, if 
furnished, will assist the commission in
identifying security holders and, therefore, in
 promptly processing statements of
beneficial ownership of securities.
Failure to disclose the information requested by
 this schedule, except for I.R.S.
identification numbers, may result in civil or 
criminal action against the persons involved
for violation of the Federal securities laws and
 rules promulgated thereunder.
General Instructions
Statements filed pursuant to Rule 13d-1(b) 
containing the information required by this
schedule shall be filed not later than February 14
 following the calendar year covered by
the statement or within the time specified in Rules
 13d1(b)(2) and 13d-2(c). Statements
filed pursuant to Rule 13d-1(c) shall be filed 
within the time specified in Rules 13d-1(c),
13d- 2(b) and 13d-2(d). Statements filed pursuant
 to Rule

13d-1(d) shall be filed not later
than February 14 following the calendar year
 covered by the statement pursuant to Rules

13d-1(d) and 13d-2(b).
Information contained in a form which is required
 to be filed by rules under Section 13(f)
for the same calendar year as that covered by a 
statement on this schedule may be
incorporated by reference in response to any of 
the items of this schedule. If such
information is incorporated by reference in this
 schedule, copies of the relevant pages of
such form shall be filed as an exhibit to this 
schedule.
The item numbers and captions of the items shall
 be included but the text of the items is
to be omitted. The answers to the items shall be
 so prepared as to indicate clearly the
coverage of the items without referring to the
 text of the items. Answer every item. If an
item is inapplicable or the answer is in the 
negative, so state.
Item 1.
Item 1(a) Name of issuer: Curon Medical Inc.
Item 1(b) Address of issuer's principal executive 
offices: 
46117 Landing Parkway
Fremont CA 94538
Item 2.
2(a) Name of person filing: Goldman Capital Management 
Inc. 2(b) Address or principal business office or, if
 none, residence:320 Park Ave. 10th floor
New York, NY 10022
2(c) Citizenship: US
2(d) Title of class of securities: Common
2(e) CUSIP No.:231292103
Item 3.
If this statement is filed pursuant to Rules 13d-1(b),
 or 13d-2(b) or (c), check whether

the person filing is a:
[X ] Broker or dealer registered under Section 15 of 
the Act.
[ ] Bank as defined in Section 3(a)(6) of the Act.
[ ] Insurance company as defined in Section 3(a)(19) 
of the Act.
[ ] Investment company registered under Section 8 of 
the Investment Company Act of 1940.
[ ] An investment adviser in accordance with Rule 
13d1(b)(1)(ii)(E);

[ ] An employee benefit plan or endowment fund in
 accordance with Rule 13d-1(b)(1)(ii)(F);
[ ] A parent holding company or control person in
 accordance with Rule 13d-1(b)(1)(ii)(G);
[ ] A savings associations as defined in Section 3(b)
 of the Federal Deposit Insurance Act
(12 U.S.C. 1813);
[ ] A church plan that is excluded from the 
definition of an investment company under
section 3(c)(14) of the Investment Company Act
 of 1940;
[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Item 4. Ownership
Provide the following information regarding the 
aggregate number and percentage of the
class of securities of the issuer identified in 
Item 1. Amount beneficially owned: 2407670
Percent of class 5.6
Number of shares as to which such person has:

Sole power to vote or to direct the vote:
2407670
Shared power to vote or to direct the vote
Sole power to dispose or to direct the disposition
 of Shared power to dispose or to direct the 
disposition of
Instruction. For computations regarding securities

 which represent a right to acquire an

underlying security see Rule 13d-3(d)(1).
Item 5.
Ownership of 5 Percent or Less of a Class. If this
 statement is being filed to report the
fact that as of the date hereof the reporting person
 has ceased to be the beneficial owner
of more than 5 percent of the class of securities, 
check the following [ ].
Instruction. Dissolution of a group requires a 
response to this item.
Item 6. Ownership of More than 5 Percent on Behalf
 of Another Person
If any other person is known to have the right to 
receive or the power to direct the
receipt of dividends from, or the proceeds from the
 sale of, such securities, a statement
to that effect should be included in response to 
this item
and, if such interest relates to
more than 5 percent of the class, such person should 
be identified. A listing of the
shareholders of an investment company registered
 under the Investment Company Act of 1940
or the beneficiaries of employee benefit plan, 
pension fund or endowment fund is not
required.
N/A
Item 7. Identification and Classification of the 
Subsidiary Which Acquired the Security
Being Reported on by the Parent Holding Company or
 Control Person.
If a parent holding company or control person has 
filed this schedule pursuant to Rule
13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and
 attach an exhibit stating the identity
and the Item 3 classification of the relevant 
subsidiary. If a parent holding company or
control person has filed this schedule pursuant to
 Rule 13d1(c) or Rule 13d-1(d), attach
an exhibit stating the identification of the relevant
 subsidiary.
N/A
Item 8. Identification and Classification of Members
 of the Group
If a group has filed this schedule pursuant to Rule 
13d1(b)(ii)(J), so indicate under Item
3(j) and attach an exhibit stating the identity and
 Item 3 classification of each member of
the group. If a group has filed this schedule 
pursuant to Rule 13d-1(c) or Rule 13d-1(d),
attach an exhibit stating the identity of each 
member of the group.
N/A
Item 9. Notice of Dissolution of Group
Notice of dissolution of a group may be furnished
 as an exhibit stating the date of the
dissolution and that all further filings with 
respect to transactions in the security
reported on will be filed, if required, by members
 of the group, in their individual
capacity. See Item 5.
N/A
Item 10. Certifications
The following certification shall be included if 
the statement is filed pursuant to Rule
13d-1(b):
By signing below I certify that, to the best of my
 knowledge and belief, the securities
referred to above were acquired and are held in the
 ordinary course of business and were
not acquired and are not held for the purpose of or
 with the effect of changing or
influencing the control of the issuer of the 
securities and
were not acquired and are not
held in connection with or as a participant in any
 transaction having that purpose or
effect.
The following certification shall be included if
 the statement is filed pursuant to Rule
13d-1(c):
By signing below I certify that, to the best of
 my knowledge and belief, the securities
referred to above were not acquired and are not 
held for the purpose of or with the effect
of changing or influencing the control of the 
issuer of the securities and were not
acquired and are not held in connection with or
 as a participant in any transaction having
that purpose or effect.
Signature. Neal I Goldman
After reasonable inquiry and to the best of my 
knowledge and belief, I certify that the
information set forth in this statement is true,
 complete and correct.
Dated: January 5, 2006
Signature Neal I Goldman
Name/Title Neal I Goldman , President
The original statement shall be signed by each
 person on whose behalf the statement is
filed or his authorized representative. If the
 statement is signed on behalf of a person by
his authorized representative other than an 
executive officer or general partner of the
filing person, evidence of the representative's
 authority to sign on behalf of such person
shall be filed with the statement, provided, however,
 that a power of attorney for this
purpose which is already on file with the Commission
 may be incorporated by reference. The
name and any title of each person who signs the 
statement shall be typed or printed beneath
his signature.
Note: Schedules filed in paper format shall include
 a signed original and five copies of
the schedule, including all exhibits. See Rule 13d-7
 for other parties for whom copies are
to be sent.
Attention: Intentional misstatements or omissions
 of fact constitute Federal criminal

violations (see 18 U.S.C. 1001).

Regulatory History
43 FR 18499, April 28, 1978, as amended at 43 
FR 55756, Nov. 29, 1978; 44 FR 2148, Jan. 9,
1979; 44 FR 11751, March 2, 1979; 61 FR 49957,
 49959, Sept. 24, 1996; 62 FR 35338, 35340,
July 1, 1997; 63 FR 2854, 2867, Jan. 16, 1998,
 as corrected at 63 FR 15286, 15287, March
31, 1998
Return to top
Previous HYPERLINK "http://www.law.uc.edu/CCL/
34ActRls/reg13D.html" Contents HYPERLINK "http:
//www.law.uc.edu/CCL/34ActRls/rule13e-1.html"Next